Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

about

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

Item

http://www.wikidata.org/entity/Q51527350

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@en

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@nl

type

Item

label

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@en

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@nl

prefLabel

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@en

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@nl

P1476

Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.

@en

P2093

Fuyu Guan

http://www.w3.org/2001/XMLSchema#string

Lawrence R Soma

http://www.w3.org/2001/XMLSchema#string

Mary A Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

A functional comparison of ovine and porcine trypsins.

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.

Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.

Detection, quantification, and identification of dermorphin in equine plasma and urine by LC-MS/MS for doping control.

Fragmentation pathways of protonated peptides.

Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis.

The horse as a model of naturally occurring osteoarthritis.

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.

Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers.

Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis.

P304

1421-1431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.2091

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27609063

http://www.w3.org/2001/XMLSchema#string